how long has semaglutide been fda approved Oral Gets Approval for CV Event Reduction in High-risk Diabetes Patients FDA Approves First ORAL GLP-1

With more new products in the pipeline, Acevedo said, Danone North America is hoping to bring in more younger consumers into the fold

Using a lower "maintenance" or "micro-dose" of GLP-1 agonists is a strategy some clinicians use for long-term weight management

The STEP UP and STEP UP T2D clinical trials are the first to investigate whether increasing the dose of semaglutide from the currently approved dose of 2.4 mg to 7.2mg is safe and leads to additional weight reduction

The 2026 consensus remains: is semaglutide safe

For diabetes patients specifically, TRANSCEND-T2D-1 suggests meaningfully better tolerability than the general obesity population worth factoring into expectation-setting

When combined with insulin or sulfonylureas, there is an increased risk of hypoglycaemia